Restoration of Listing - THC Dartford Issuer Plc

Hospital Co (Dartford) Issuer PLC
31 March 2025
 

The Hospital Company (Dartford) Issuer Plc

NOTIFICATION UPDATE ON RESTORATION OF LISTING FROM THE OFFICIAL LIST

The Hospital Company (Dartford) Issuer plc (the "Company") provides the following update in relation to the temporary suspension of the Company's £152,525,000 (including £20,000,000 variation Bonds) 3.003 per cent. Index-Linked Guaranteed Secured Bonds due 2031 (the "Bonds") on the Main Market of the London Stock Exchange from 07:30 am on 1 August 2024 to 2:30pm on 31 March 2025. Effective from 2.30 pm on 31 March 2025, The Hospital Company (Dartford) Issuer plc confirms that The Financial Conduct Authority restored the Company's Bonds to the Main Market of the London Stock Exchange as set out below.

 Security Description     

ISIN

3.003% Index-Linked Guaranteed Secured Bonds due 31/10/2031; fully paid; (Represented by bonds to bearer of GBP1,000, GBP10,000
 & GBP100,000 each) (Regulation S)

XS0166025824

 

The RNS confirming the restoration of listing to the official list being effective from 2.30 pm on 31 March 2025 was released within the Official List Notice (see link below).

Restoration - The Hospital Company (Dartford) - 14:30:00 31 Mar 2025 - News article | London Stock Exchange 

This notification update has been provided for ease of communication to re-confirm the restoration of the Company's Bonds on the Main Market of the London Stock Exchange.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings